170 related articles for article (PubMed ID: 32178826)
1. Techniques for the generation of humanized mouse models for immuno-oncology.
Yu CI; Marches F; Wu TC; Martinek J; Palucka K
Methods Enzymol; 2020; 636():351-368. PubMed ID: 32178826
[TBL] [Abstract][Full Text] [Related]
2. Large-cohort humanized NPI mice reconstituted with CD34
Xu X; Gu H; Li H; Gao S; Shi X; Shen J; Li B; Wang H; Zheng K; Shao Z; Cheng P; Cha Z; Peng S; Nie Y; Li Z; Guo S; Qian B; Jin G
FASEB J; 2022 Apr; 36(4):e22244. PubMed ID: 35262964
[TBL] [Abstract][Full Text] [Related]
3. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
[TBL] [Abstract][Full Text] [Related]
4. Modeling Tumor Immunology and Immunotherapy in Mice.
Buqué A; Galluzzi L
Trends Cancer; 2018 Sep; 4(9):599-601. PubMed ID: 30149876
[TBL] [Abstract][Full Text] [Related]
5. The humanized mouse: Emerging translational potential.
Morton JJ; Alzofon N; Jimeno A
Mol Carcinog; 2020 Jul; 59(7):830-838. PubMed ID: 32275343
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.
Siegler EL; Wang P
Hum Gene Ther; 2018 May; 29(5):534-546. PubMed ID: 29390873
[TBL] [Abstract][Full Text] [Related]
7. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
[TBL] [Abstract][Full Text] [Related]
8. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial.
Brendel C; Rio P; Verhoeyen E
Biochem Pharmacol; 2020 Apr; 174():113711. PubMed ID: 31726047
[TBL] [Abstract][Full Text] [Related]
9. Humanized Mouse Models for Immuno-oncology Drug Discovery.
Kumari R; Feuer G; Bourré L
Curr Protoc; 2023 Aug; 3(8):e852. PubMed ID: 37552031
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model.
Teng R; Zhao J; Zhao Y; Gao J; Li H; Zhou S; Wang Y; Sun Q; Lin Z; Yang W; Yin M; Wen J; Deng H
J Immunother; 2019; 42(2):33-42. PubMed ID: 30586347
[TBL] [Abstract][Full Text] [Related]
11. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy.
Lin X; Zeng T; Lin J; Zhang Q; Cheng H; Fang S; Lin S; Chen Y; Xu Y; Lin J
Cancer Biol Ther; 2020; 21(2):130-138. PubMed ID: 31690181
[TBL] [Abstract][Full Text] [Related]
12. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
Wang M; Yao LC; Cheng M; Cai D; Martinek J; Pan CX; Shi W; Ma AH; De Vere White RW; Airhart S; Liu ET; Banchereau J; Brehm MA; Greiner DL; Shultz LD; Palucka K; Keck JG
FASEB J; 2018 Mar; 32(3):1537-1549. PubMed ID: 29146734
[TBL] [Abstract][Full Text] [Related]
13. Progress, implications, and challenges in using humanized immune system mice in CAR-T therapy-Application evaluation and improvement.
Yue H; Bai L
Animal Model Exp Med; 2024 Feb; 7(1):3-11. PubMed ID: 37823214
[TBL] [Abstract][Full Text] [Related]
14. Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice.
Choi Y; Lee S; Kim K; Kim SH; Chung YJ; Lee C
Exp Mol Med; 2018 Aug; 50(8):1-9. PubMed ID: 30089794
[TBL] [Abstract][Full Text] [Related]
15. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy.
Lin S; Huang G; Cheng L; Li Z; Xiao Y; Deng Q; Jiang Y; Li B; Lin S; Wang S; Wu Q; Yao H; Cao S; Li Y; Liu P; Wei W; Pei D; Yao Y; Wen Z; Zhang X; Wu Y; Zhang Z; Cui S; Sun X; Qian X; Li P
MAbs; 2018; 10(8):1301-1311. PubMed ID: 30204048
[TBL] [Abstract][Full Text] [Related]
16. The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer.
Carrillo MA; Zhen A; Kitchen SG
Front Immunol; 2018; 9():746. PubMed ID: 29755454
[TBL] [Abstract][Full Text] [Related]
17. Purinergic targeting enhances immunotherapy of CD73
Wang J; Lupo KB; Chambers AM; Matosevic S
J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
[TBL] [Abstract][Full Text] [Related]
18. Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.
Morton JJ; Keysar SB; Perrenoud L; Chimed TS; Reisinger J; Jackson B; Le PN; Nieto C; Gomez K; Miller B; Gao D; Somerset H; Wang XJ; Jimeno A
Mol Carcinog; 2018 Nov; 57(11):1651-1663. PubMed ID: 30129680
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
[TBL] [Abstract][Full Text] [Related]
20. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.
Morton JJ; Bird G; Keysar SB; Astling DP; Lyons TR; Anderson RT; Glogowska MJ; Estes P; Eagles JR; Le PN; Gan G; McGettigan B; Fernandez P; Padilla-Just N; Varella-Garcia M; Song JI; Bowles DW; Schedin P; Tan AC; Roop DR; Wang XJ; Refaeli Y; Jimeno A
Oncogene; 2016 Jan; 35(3):290-300. PubMed ID: 25893296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
